These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 21220229)

  • 21. Overactive bladder syndrome and lower urinary tract symptoms after prostate cancer treatment.
    Biers S; Sievert KD; Thiruchelvam N
    Curr Opin Urol; 2017 May; 27(3):307-313. PubMed ID: 28267055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined inflatable penile prosthesis-artificial urinary sphincter implantation: no increased risk of adverse events compared to single or staged device implantation.
    Segal RL; Cabrini MR; Harris ED; Mostwin JL; Bivalacqua TJ; Burnett AL
    J Urol; 2013 Dec; 190(6):2183-8. PubMed ID: 23831315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of erectile dysfunction and LUTS/incontinence: the two most common, long-term side effects of prostate cancer treatment.
    Shabataev V; Saadat SH; Elterman DS
    Can J Urol; 2020 Feb; 27(27 Suppl 1):17-24. PubMed ID: 32101696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time course and predictors of symptoms after primary prostate cancer therapy.
    Talcott JA; Manola J; Clark JA; Kaplan I; Beard CJ; Mitchell SP; Chen RC; O'Leary MP; Kantoff PW; D'Amico AV
    J Clin Oncol; 2003 Nov; 21(21):3979-86. PubMed ID: 14581420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erectile dysfunction and urinary incontinence after prostate cancer treatment.
    Mirza M; Griebling TL; Kazer MW
    Semin Oncol Nurs; 2011 Nov; 27(4):278-89. PubMed ID: 22018407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radical prostatectomy for localized prostate cancer provides durable cancer control with excellent quality of life: a structured debate.
    Walsh PC
    J Urol; 2000 Jun; 163(6):1802-7. PubMed ID: 10799186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics and management of erectile dysfunction after various treatments for prostate cancer.
    Soh J; Kaiho Y; Kikuchi E; Oya M; Yoshioka K; Nakagami Y; Hatano T; Ozu C; Horiguchi Y; Namiki K; Tachibana M; Hisasue S; Tanaka N; Asakawa I
    Int J Urol; 2010 Aug; 17(8):689-97. PubMed ID: 20590940
    [No Abstract]   [Full Text] [Related]  

  • 28. What happened? Sexual consequences of prostate cancer and its treatment.
    Katz A
    Can Fam Physician; 2005 Jul; 51(7):977-82. PubMed ID: 16060176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer.
    Gore JL; Kwan L; Lee SP; Reiter RE; Litwin MS
    J Natl Cancer Inst; 2009 Jun; 101(12):888-92. PubMed ID: 19509365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of medications or devices for erectile dysfunction among long-term prostate cancer treatment survivors: potential influence of sexual motivation and/or indifference.
    Miller DC; Wei JT; Dunn RL; Montie JE; Pimentel H; Sandler HM; McLaughlin PW; Sanda MG
    Urology; 2006 Jul; 68(1):166-71. PubMed ID: 16844457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update on erectile dysfunction in prostate cancer patients.
    Kendirci M; Bejma J; Hellstrom WJ
    Curr Opin Urol; 2006 May; 16(3):186-95. PubMed ID: 16679857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.
    Potosky AL; Davis WW; Hoffman RM; Stanford JL; Stephenson RA; Penson DF; Harlan LC
    J Natl Cancer Inst; 2004 Sep; 96(18):1358-67. PubMed ID: 15367568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Quality of life after radiotherapy for prostate cancer].
    Joly F; Degrendel AC; Guizard AV
    Cancer Radiother; 2010 Oct; 14(6-7):519-25. PubMed ID: 20728393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Urinary incontinence in men].
    Bauer RM; Oelke M; Hübner W; Grabbert M; Kirschner-Hermanns R; Anding R
    Urologe A; 2015 Jun; 54(6):887-99; quiz 900. PubMed ID: 26081822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of the incontinent patient with a sphincteric stricture following radical prostatectomy.
    Cox A; Herschorn S
    Curr Opin Urol; 2014 Nov; 24(6):578-85. PubMed ID: 25203243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of tadalafil treatment on erectile function recovery following bilateral nerve-sparing radical prostatectomy: a randomised placebo-controlled study (REACTT).
    Montorsi F; Brock G; Stolzenburg JU; Mulhall J; Moncada I; Patel HR; Chevallier D; Krajka K; Henneges C; Dickson R; Büttner H
    Eur Urol; 2014 Mar; 65(3):587-96. PubMed ID: 24169081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of end-stage erectile dysfunction and stress urinary incontinence after radical prostatectomy by simultaneous dual implantation using a single trans-scrotal incision: surgical technique and outcomes.
    Martínez-Salamanca JI; Espinós EL; Moncada I; Portillo LD; Carballido J
    Asian J Androl; 2015; 17(5):792-6. PubMed ID: 25657083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous penile prosthesis and male sling/artificial urinary sphincter.
    Lee D; Romero C; Alba F; Westney OL; Wang R
    Asian J Androl; 2013 Jan; 15(1):10-5. PubMed ID: 23202702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current management of erectile dysfunction after cancer treatment.
    Peltier A; van Velthoven R; Roumeguère T
    Curr Opin Oncol; 2009 Jul; 21(4):303-9. PubMed ID: 19509501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. State of the art on stress incontinence management after benign prostatic obstruction surgery.
    Sabbagh P; Dupuis H; Cornu JN
    Curr Opin Urol; 2021 Sep; 31(5):473-478. PubMed ID: 34397505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.